Aptamer extends contract with Unilever to progress Optimer for deodorant development Post author: Post published:September 3, 2024 Post category:uncategorized Lab-test results of Optimer indicate good applicability in deodorant products. You Might Also Like Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17 November 12, 2024 Recombinant zoster vaccine well tolerated by patients with inflammatory RMD June 11, 2025 Trametinib: Potential therapeutic game-changer for Alzheimer’s disease October 4, 2023
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17 November 12, 2024